{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T05:48:37Z","timestamp":1771566517835,"version":"3.50.1"},"reference-count":6,"publisher":"Elsevier BV","issue":"5-6","license":[{"start":{"date-parts":[[2004,1,1]],"date-time":"2004-01-01T00:00:00Z","timestamp":1072915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2004,1]]},"DOI":"10.1016\/j.vaccine.2003.08.034","type":"journal-article","created":{"date-parts":[[2003,10,11]],"date-time":"2003-10-11T04:49:49Z","timestamp":1065847789000},"page":"766-772","source":"Crossref","is-referenced-by-count":36,"title":["A post-licensure evaluation of the safety of inactivated hepatitis A vaccine (VAQTA\u00ae, Merck) in children and adults"],"prefix":"10.1016","volume":"22","author":[{"given":"Steven","family":"Black","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henry","family":"Shinefield","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edwin","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Coplan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"17","key":"10.1016\/j.vaccine.2003.08.034_BIB1","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1056\/NEJM198510243131706","article-title":"Type A viral hepatitis, new developments in an old disease","volume":"313","author":"Lemon","year":"1985","journal-title":"NEJM"},{"issue":"4","key":"10.1016\/j.vaccine.2003.08.034_BIB2","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1093\/oxfordjournals.aje.a113339","article-title":"Hepatitis A infection in households","volume":"115","author":"Villarejos","year":"1982","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.vaccine.2003.08.034_BIB3","unstructured":"Viral hepatitis A. MMWR 1999;48:RR 1\u201312."},{"issue":"7","key":"10.1016\/j.vaccine.2003.08.034_BIB4","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1056\/NEJM199208133270702","article-title":"A controlled trial of formalin inactivated hepatitis A vaccine in healthy children","volume":"327","author":"Wertzberger","year":"1992","journal-title":"NEJM"},{"issue":"12","key":"10.1016\/j.vaccine.2003.08.034_BIB5","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1097\/00006454-199912000-00003","article-title":"Postmarketing evaluation of the safety and effectiveness of varicella vaccine","volume":"18","author":"Black","year":"1999","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.vaccine.2003.08.034_BIB6","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1097\/00006454-199511000-00011","article-title":"Postlicensure surveillance for Haemophilus influenzae type b invasive disease after use of Haemophilus influenzae type b oligosaccharide CRM197 conjugate vaccine in a large defined United States population: a four-year eight-month follow-up","volume":"14","author":"Shinefield","year":"1995","journal-title":"Pediatr. Infect. Dis. J."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X03006510?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X03006510?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,20]],"date-time":"2019-02-20T22:58:03Z","timestamp":1550703483000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X03006510"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,1]]},"references-count":6,"journal-issue":{"issue":"5-6","published-print":{"date-parts":[[2004,1]]}},"alternative-id":["S0264410X03006510"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2003.08.034","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2004,1]]}}}